No Data
Volume change rate ranking (9 o'clock) ~ ABEJA, Kasumigaseki CA, etc. ranked
In the volume change rate ranking, you can understand the market participants' interest such as trends in speculative activities by comparing the average volume of the last 5 days with the volume on the day of distribution. Top Volume Change Rate [As of 9:32 on October 3] (Compared to the average volume of the last 5 days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <133A> GX Super Short Grain 31011 107,185.08 204.85% 0.0215
Stocks that moved the previous day part2 include Cellseed, Plaid, etc.
Stock name 26th closing price ⇒ Previous day comparison * CellSeed <7776> 718 -61It is expected that the start of clinical trials for the same species chondrocyte sheet (CLS2901C) will be delayed. * Plaid <4165> 968 +19In September of the fourth year, the business performance estimate was revised upwards, causing a surge in popularity the previous day but struggling to grow. Today is dominated by buying. * INTLOOP <9556> 5130 -50It was bought the day before due to capital business alliances with Idein, which handles Edge AI platforms. Today, popularity is scattered.
Despite softness and the rise in long-term US interest rates, the lower levels appear to be holding firm.
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to have a soft opening. In the US stock market on the 25th yesterday, the Dow Jones fell by 293.47 points (-0.70%) to 41,914.75, marking a decline for the first time in 5 days. The Dow Jones had been setting record highs consecutively until the previous day, leading to profit-taking selling, and the decline in August new home sales from July added to the pressure on stock prices. The Nasdaq was weighed down by the rise in long-term interest rates, but the semiconductor sector remained strong, providing support at lower levels and closing trading with a slight gain.
Noil Immun, Carna Bio, and others.
Collaborative relationship company stock sale profit of 6.4 billion yen expected to be recorded as special profit for <3908> Capital increase through third-party allotment by Carnabyo (1,056,00 shares) for <4572> Approximately 1.4 billion yen in subsidy income from Saifyuz to be recorded as non-operating income for <4892> Takara Bio <4974> and business alliance in the development of Noil Immun NIB103 <4893> <7776> Seaseed's clinical trial start date for homologous chondrocyte sheet (CLS2901C) is expected to be delayed.
The Tokyo Stock Exchange Growth Market Index fell slightly, lacking direction for the day.
Tokyo Stock Exchange Growth Market Index 852.05 -1.71 / Volume 0.2 billion 3.11 million shares / Trading value 127.2 billion yen Tokyo Stock Exchange Growth Market 250 Index 667.65 -1.36 / Volume 0.1 billion 12.09 million shares / Trading value 104.8 billion yen Today's growth market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index, experienced a slight decline. The number of rising stocks is 226, the number of declining stocks is 325, and unchanged stocks are 36. In the US market on the 30th, the Dow Jones Average was up 228.03 dollars to 41563.
Individual investor Yusuke Yugen: If the biotech stocks become popular, here are 6 stocks to check out【FISCO Social Reporter】
The following is a comment written by individual investor "Yuugentei Tamisuke", who is a FISCO Social Reporter (Blog: Profitable Stock Information "Nekodanna's Unceilinged Stocks"). At FISCO, we strive to actively collaborate with individuals who proactively disseminate information, in order to provide a wider range of information to investors. -----------*It seems that the government's plan to support bioventure has been revealed in the media as of August 25, 2024 at 3:00 PM.
No Data
No Data